Indianapolis, IN, United States of America

Kristin M Westerfield

This inventor holds 11 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Roche Diabetes Care, Inc., Roche Diagnostics Operations, Inc., Polymer Technology Systems, Inc.. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristin M Westerfield. Retrieved from https://idiyas.com/inventor/kristin-m-westerfield

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 81.8

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 176(Granted Patents)


Location History:

  • Fortville, IN (US) (2013 - 2016)
  • Indianapolis, IN (US) (2015 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Kristin M Westerfield: Innovator in Diabetes Management

Introduction

Kristin M Westerfield is a prominent inventor based in Indianapolis, IN, known for her significant contributions to diabetes management technology. With a total of 11 patents to her name, she has developed innovative solutions aimed at improving patient safety and care.

Latest Patents

One of her latest patents focuses on customizing names of insulin delivery profiles for improved patient safety. This configuration software implements techniques for customizing names of insulin delivery profiles, which include receiving a string of characters that serve as a name for a given insulin delivery profile. The insulin delivery profile encompasses at least one parameter related to insulin delivery by an insulin pump and is part of a plurality of insulin delivery profiles associated with a specific patient. The process involves normalizing the string of characters according to a rule set, comparing the normalized string with names for each of the insulin delivery profiles, and updating the name of the given insulin delivery profile in a pump configuration file when the normalized string is unique.

Another notable patent involves systems and methods for distinguishing cotinine from anabasine in a point-of-care testing device. This system is designed to determine the levels of cotinine and anabasine in a sample, utilizing a test strip configured to receive the sample and a meter that reads the test strip to detect the levels of both substances.

Career Highlights

Throughout her career, Kristin has worked with reputable companies such as Roche Diabetes Care, Inc. and Roche Diagnostics Operations, Inc. Her experience in these organizations has allowed her to contribute to advancements in diabetes care technology.

Collaborations

Kristin has collaborated with notable professionals in her field, including Mark Gilmore Mears and Phillip Edgar Pash. These collaborations have further enhanced her innovative work and contributions to diabetes management.

Conclusion

Kristin M Westerfield stands out as a dedicated inventor whose work has significantly impacted diabetes management. Her innovative patents and collaborations reflect her commitment to improving patient safety and care in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…